BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu Y, Chi L, Kuebler WM, Goldenberg NM. Perivascular Inflammation in Pulmonary Arterial Hypertension. Cells 2020;9:E2338. [PMID: 33105588 DOI: 10.3390/cells9112338] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu J, Liang C, Li J. A signal recognition particle-related joint model of LASSO regression, SVM-RFE and artificial neural network for the diagnosis of systemic sclerosis-associated pulmonary hypertension. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.1078200] [Reference Citation Analysis]
2 Liu S, Nambiar Veetil N, Li Q, Kucherenko MM, Knosalla C, Kuebler WM. Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening. Front Immunol 2022;13:959209. [DOI: 10.3389/fimmu.2022.959209] [Reference Citation Analysis]
3 Pan Y, Chen A, Wang X, Bao C, Liang S, Tang H, Han Y. Saluisn-β contributes to endothelial dysfunction in monocrotaline-induced pulmonary arterial hypertensive rats. Biomed Pharmacother 2022;155:113748. [PMID: 36174379 DOI: 10.1016/j.biopha.2022.113748] [Reference Citation Analysis]
4 Bouchet C, Cardouat G, Douard M, Coste F, Robillard P, Delcambre F, Ducret T, Quignard J, Vacher P, Baudrimont I, Marthan R, Berger P, Guibert C, Freund-michel V. Inflammation and Oxidative Stress Induce NGF Secretion by Pulmonary Arterial Cells through a TGF-β1-Dependent Mechanism. Cells 2022;11:2795. [DOI: 10.3390/cells11182795] [Reference Citation Analysis]
5 Wang J, Uddin MN, Wang R, Gong Y, Wu Y. Comprehensive analysis and validation of novel immune and vascular remodeling related genes signature associated with drug interactions in pulmonary arterial hypertension. Front Genet 2022;13:922213. [DOI: 10.3389/fgene.2022.922213] [Reference Citation Analysis]
6 Liu X, Zhang L, Zhang W. Metabolic reprogramming: A novel metabolic model for pulmonary hypertension. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.957524] [Reference Citation Analysis]
7 Li T, Liu B, Li NS, Luo XJ, Peng JW, Peng J. Vascular peroxidase 1 promotes phenotypic transformation of pulmonary artery smooth muscle cells via ERK pathway in hypoxia-induced pulmonary hypertensive rats. Life Sci 2022;307:120910. [PMID: 36029851 DOI: 10.1016/j.lfs.2022.120910] [Reference Citation Analysis]
8 Chen J, Miao J, Zhou D, Liao J, Wang Z, Lin Z, Zhang C, Luo X, Li Y, Li X, Liu S, Xing Y, Zhang Z, Zhao M, Parmisano S, Chen Y, Yuan JX, Yang K, Sun D, Wang J. Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension. Thromb Res 2022;218:52-63. [PMID: 35988445 DOI: 10.1016/j.thromres.2022.08.006] [Reference Citation Analysis]
9 Rodriguez-irizarry VJ, Schneider AC, Ahle D, Smith JM, Suarez-martinez EB, Salazar EA, Mcdaniel Mims B, Rasha F, Moussa H, Moustaïd-moussa N, Pruitt K, Fonseca M, Henriquez M, Clauss MA, Grisham MB, Almodovar S. Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertension. Front Immunol 2022;13:936164. [DOI: 10.3389/fimmu.2022.936164] [Reference Citation Analysis]
10 Zhao H, Gong S, Shi Y, Luo C, Qiu H, He J, Sun Y, Huang Y, Wang S, Miao Y, Wu W. The role of prolactin/vasoinhibins in cardiovascular diseases. Animal Model Exp Med 2022. [PMID: 35923071 DOI: 10.1002/ame2.12264] [Reference Citation Analysis]
11 Ma R, Cheng L, Song Y, Sun Y, Gui W, Deng Y, Xie C, Liu M. Altered Lung Microbiome and Metabolome Profile in Children With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease. Front Med 2022;9. [DOI: 10.3389/fmed.2022.940784] [Reference Citation Analysis]
12 Chen T, Su S, Yang Z, Zhang D, Li Z, Lu D. Srolo Bzhtang reduces inflammation and vascular remodeling via suppression of the MAPK/NF-κB signaling pathway in rats with pulmonary arterial hypertension. J Ethnopharmacol 2022;:115572. [PMID: 35872290 DOI: 10.1016/j.jep.2022.115572] [Reference Citation Analysis]
13 António T, Soares-da-Silva P, Pires NM, Gomes P. Salt-inducible kinases: new players in pulmonary arterial hypertension? Trends Pharmacol Sci 2022:S0165-6147(22)00135-3. [PMID: 35851157 DOI: 10.1016/j.tips.2022.06.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Wagner K. The Editor’s Choice Articles—Section “Cells of the Cardiovascular System” 2020–2021. Cells 2022;11:2173. [DOI: 10.3390/cells11142173] [Reference Citation Analysis]
15 Ni S, Ji T, Dong J, Chen F, Feng H, Zhao H, Chen D, Ma W. Immune Cells in Pulmonary Arterial Hypertension. Heart Lung Circ 2022;31:934-43. [PMID: 35361533 DOI: 10.1016/j.hlc.2022.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Li C, Zhu H, Zhang S, Meng F, Li S, Li G, Zha J, Wu S, Zhu L, Dai A. Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response. Phytomedicine 2022;102:154171. [DOI: 10.1016/j.phymed.2022.154171] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Tabeling C, González Calera CR, Lienau J, Höppner J, Tschernig T, Kershaw O, Gutbier B, Naujoks J, Herbert J, Opitz B, Gruber AD, Hocher B, Suttorp N, Heidecke H, Burmester GR, Riemekasten G, Siegert E, Kuebler WM, Witzenrath M. Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension. Front Immunol 2022;13:895501. [PMID: 35757687 DOI: 10.3389/fimmu.2022.895501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Ji D, Qiao Y, Guan X, Zhang T. Serum miR-204 and miR-451 Expression and Diagnostic Value in Patients with Pulmonary Artery Hypertension Triggered by Congenital Heart Disease. Comput Math Methods Med 2022;2022:9430708. [PMID: 35734774 DOI: 10.1155/2022/9430708] [Reference Citation Analysis]
19 van Uden D, Koudstaal T, van Hulst JAC, Vink M, van Nimwegen M, van den Toorn LM, Chandoesing PP, van den Bosch AE, Kool M, Hendriks RW, Boomars KA. Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity. Int J Mol Sci 2022;23:6508. [PMID: 35742956 DOI: 10.3390/ijms23126508] [Reference Citation Analysis]
20 Tu J, Jin J, Chen X, Sun L, Cai Z. Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. Front Immunol 2022;13:868983. [PMID: 35663995 DOI: 10.3389/fimmu.2022.868983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang R, Yuan T, Wang J, Chen Y, Zhao J, Li M, Fang L, Du G. Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective. Pharmacological Research 2022;180:106238. [DOI: 10.1016/j.phrs.2022.106238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Krzyżewska A, Baranowska-kuczko M, Jastrząb A, Kasacka I, Kozłowska H. Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension. Molecules 2022;27:3327. [DOI: 10.3390/molecules27103327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Rong W, Liu C, Li X, Wan N, Wei L, Zhu W, Bai P, Li M, Ou Y, Li F, Wang L, Wu X, Liu J, Xing M, Zhao X, Liu H, Zhang H, Lyu A. Caspase-8 Promotes Pulmonary Hypertension by Activating Macrophage-Associated Inflammation and IL-1β (Interleukin 1β) Production. Arterioscler Thromb Vasc Biol 2022;42:613-31. [PMID: 35387479 DOI: 10.1161/ATVBAHA.121.317168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Germande O, Ducret T, Quignard J, Deweirdt J, Freund-michel V, Errera M, Cardouat G, Vacher P, Muller B, Berger P, Guibert C, Baudrimont M, Baudrimont I. NiONP-Induced Oxidative Stress and Mitochondrial Impairment in an In Vitro Pulmonary Vascular Cell Model Mimicking Endothelial Dysfunction. Antioxidants 2022;11:847. [DOI: 10.3390/antiox11050847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Baptista de Barros Ribeiro Dourado LP, Santos M, Moreira-Gonçalves D. Nets, pulmonary arterial hypertension, and thrombo-inflammation. J Mol Med (Berl) 2022. [PMID: 35441845 DOI: 10.1007/s00109-022-02197-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Parajuli N, Kosanovic D. Editorial: Oxidative Stress in Cardiovascular Diseases and Pulmonary Hypertension. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.868988] [Reference Citation Analysis]
27 Yoshida T, Nagaoka T, Nagata Y, Suzuki Y, Tsutsumi T, Kuriyama S, Watanabe J, Togo S, Takahashi F, Matsushita M, Joki Y, Konishi H, Nunomura S, Izuhara K, Conway SJ, Takahashi K. Periostin-related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF-2 signalling. Respirology 2022. [PMID: 35318760 DOI: 10.1111/resp.14249] [Reference Citation Analysis]
28 Funk-hilsdorf TC, Behrens F, Grune J, Simmons S. Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer. Front Physiol 2022;13:819145. [DOI: 10.3389/fphys.2022.819145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yuan C, Dang J, Han Y, Liu C, Yu S, Lv Y, Cui Y, Wang Z, Li G. Preparative isolation of maltol glycoside from Dianthus superbus and its anti-inflammatory activity in vitro. RSC Adv 2022;12:5031-41. [PMID: 35425507 DOI: 10.1039/d1ra07273k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Foley A, Steinberg BE, Goldenberg NM. Inflammasome Activation in Pulmonary Arterial Hypertension. Front Med (Lausanne) 2021;8:826557. [PMID: 35096915 DOI: 10.3389/fmed.2021.826557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 Kuret T, Sodin-šemrl S. The Role of Fibroblasts in Atherosclerosis Progression. Fibroblasts - Advances in Inflammation, Autoimmunity and Cancer 2021. [DOI: 10.5772/intechopen.98546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Kumar S, Frid MG, Zhang H, Li M, Riddle S, Brown RD, Yadav SC, Roy MK, Dzieciatkowska ME, D'Alessandro A, Hansen KC, Stenmark KR. Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages. JCI Insight 2021;6:e148382. [PMID: 34499621 DOI: 10.1172/jci.insight.148382] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
33 Bu Y, Wu H, Deng R, Wang Y. Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases. Front Pharmacol 2021;12:733387. [PMID: 34737701 DOI: 10.3389/fphar.2021.733387] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
34 Mathew R. Critical Role of Caveolin-1 Loss/Dysfunction in Pulmonary Hypertension. Med Sci (Basel) 2021;9:58. [PMID: 34698188 DOI: 10.3390/medsci9040058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Thomas S, Manivannan S, Sawant D, Kodigepalli KM, Garg V, Conway SJ, Lilly B. miR-145 transgenic mice develop cardiopulmonary complications leading to postnatal death. Physiol Rep 2021;9:e15013. [PMID: 34523259 DOI: 10.14814/phy2.15013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Evans CE, Cober ND, Dai Z, Stewart DJ, Zhao YY. Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur Respir J 2021;58:2003957. [PMID: 33509961 DOI: 10.1183/13993003.03957-2020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 24.0] [Reference Citation Analysis]
37 Mansueto G, Di Napoli M, Campobasso CP, Slevin M. Pulmonary arterial hypertension (PAH) from autopsy study: T-cells, B-cells and mastocytes detection as morphological evidence of immunologically mediated pathogenesis. Pathol Res Pract 2021;225:153552. [PMID: 34352438 DOI: 10.1016/j.prp.2021.153552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
38 Montagnoli TL, da Silva JS, Sudo SZ, Santos AD, Gomide GF, de Sá MPL, Zapata-Sudo G. ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension. Cells 2021;10:1648. [PMID: 34209333 DOI: 10.3390/cells10071648] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
39 Nicoleau S, Fellows A, Wojciak-Stothard B. Role of Krüppel-like factors in pulmonary arterial hypertension. Int J Biochem Cell Biol 2021;134:105977. [PMID: 33839307 DOI: 10.1016/j.biocel.2021.105977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Rai N, Shihan M, Seeger W, Schermuly RT, Novoyatleva T. Genetic Delivery and Gene Therapy in Pulmonary Hypertension. Int J Mol Sci 2021;22:1179. [PMID: 33503992 DOI: 10.3390/ijms22031179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]